Company news
Verrica Pharmaceuticals Inc. news in 2020
Verrica Pharmaceuticals Inc.'s news releases, calls and decks from 2020, newest first.
Verrica Pharmaceuticals Announces Receipt of Final FDA Minutes Following Type A Meeting Regarding Resubmission of the NDA for VP-102 in Molluscum
November 16, 2020
Verrica Pharmaceuticals Announces Participation in the Jefferies Virtual London Healthcare Conference
November 11, 2020
Verrica Pharmaceuticals Announces Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with External Genital Warts (CARE-1)
November 9, 2020
Verrica Pharmaceuticals Reports Third Quarter 2020 Financial Results
November 8, 2020
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 22nd Annual Global Investment Conference
September 8, 2020
Verrica Pharmaceuticals Licenses LTX-315, A First-in-Class Oncolytic Peptide Based Immunotherapy, from Lytix Biopharma AS, for the Treatment of Dermatologic Oncology Indications
August 10, 2020
Verrica Pharmaceuticals Reports Second Quarter 2020 Financial Results
August 4, 2020
Verrica Pharmaceuticals Announces Option Agreement with Torii Pharmaceutical to Develop & Commercialize VP-102 in Japan
August 4, 2020
Verrica Pharmaceuticals Announces Dr. Lawrence Eichenfield Joins Board of Directors
July 22, 2020
Verrica Pharmaceuticals Announces Clinical and Drug Development Leadership Changes
July 22, 2020
Verrica Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
July 13, 2020
Verrica Pharmaceuticals Provides Regulatory Update on VP-102
June 28, 2020
Verrica Pharmaceuticals Announces Positive Results from Two New Pooled Analyses of the Phase 3 CAMP Trials of VP-102 in Molluscum Contagiosum
June 11, 2020
Verrica Pharmaceuticals Appoints Diem Nguyen, Ph.D., M.B.A., to its Board of Directors
June 9, 2020
Verrica Pharmaceuticals Reports First Quarter 2020 Financial Results
May 6, 2020
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results
March 12, 2020
Verrica Pharmaceuticals Announces the Hiring of Two Vice Presidents to Further Grow its Commercial Capabilities
January 28, 2020
Verrica Pharmaceuticals Announces Presentation of Positive Data from New Pooled Analysis of Phase 3 CAMP Trials of VP-102
January 17, 2020
Decks in 2020
- Investor Presentation (November 2020)
Investor deck · 56 slides · Nov 10, 2020
- Investor Presentation (September 2020)
Investor deck · 54 slides · Sep 8, 2020
- Investor Presentation (April 2020)
Investor deck · 54 slides · Apr 17, 2020
- Investor Presentation (April 2020)
Investor deck · 31 slides · April 2020
- Investor Presentation (March 2020)
Investor deck · 31 slides · Mar 2, 2020
- Technical Presentation (January 2020)
Technical · 5 slides · Jan 20, 2020